Login to Your Account



Pharma: Other News To Note


Tuesday, August 21, 2012
• Reckitt Benckiser Pharmaceuticals Inc., of Richmond, Va., said the FDA approved the 4-mg and 12-mg doses of Suboxone (buprenorphine and naloxone) sublingual film for the maintenance treatment of opioid dependence.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription